Table 3 Secondary outcomes
Vaginal Insert | Oral tablets | RR | 95% CI | |
|---|---|---|---|---|
Caesarean section, n (%) | 37 (31.9) | 52 (30.2) | 1.06 | 0.70–1.5 |
CS failed induction, n (%) | 5 (4.3) | 19 (11) | 0.39 | 0.15–1.02 |
CS threatening asphyxia, n (%) | 13 (11.2) | 16 (9.3) | 1.2 | 0.60–2.4 |
Tocolysis, n (%) | 10 (8.6) | 0 | 31 | 1.8–525 |
Scalp-pH, n (%) | 49 (42) | 42 (24.4) | 1.69 | 1.20–2.38 |
Time to vaginal delivery (h), mean | 23.7 | 46.2 | p < 0.0001 | |
Quick deliverya, n (%) | 8 (6.9) | 2 (1.2) | 6.0 | 1.3–28 |
Slow deliveryb, n (%) | 12 (10.3) | 88 (51.1) | 0.20 | 0.12–0.35 |
Oxcytocin stimulation, n (%) | 52 (44.8) | 130 (75.6) | 0.59 | 0.48–0.74 |
Balloon catheter, n (%) | 7 (6.0) | 37 (21.5) | 0.28 | 0.13–0.61 |
Artificial rupture of membranes, n (%) | 51 (44.0) | 123 (71.5) | 0.61 | 0.49–0.77 |
Feverc, n (%) | 2 (1.7) | 12 (7.0) | 0.25 | 0.06–1.08 |
Epidural, n (%) | 52 (44.8) | 134 (77.9) | 0.58 | 0.46–0.71 |
Prolonged rupture of membranesd, n (%) | 4 (3.4) | 17 (9.9) | 0.35 | 0.12–1.01 |
Postpartum haemorrhagee, n (%) | 9 (7.8) | 18 (10.5) | 0.74 | 0.35–1.59 |
Sphincter rupture, n (%) | 6 (5.2) | 6 (3.5) | 1.62 | 0.54–4.9 |
Instrumental delivery, n (%) | 19 (16.4) | 31 (18.0) | 0.91 | 0.54–1.5 |